Macrogenics (MGNX) Interest Coverage Ratio (2012 - 2026)
Macrogenics' (MGNX) quarterly Interest Coverage Ratio came in at 6.11 in Q1 2026, up 98.69% year-on-year from 3.08 in Q1 2025, and down 115.92% on a QoQ basis from 2.83 in Q4 2025.
Macrogenics (MGNX) Interest Coverage Ratio (2012 - 2026) Analysis & Trends
Macrogenics (MGNX) has 15 years of Interest Coverage Ratio data on file, last reported at 6.11 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 98.69% year-over-year to 6.11 in Q1 2026; TTM through Mar 2026 was 11.64, a 99.15% increase from a year earlier, with the FY2025 full-year figure at 8.56, down 3007.03% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 6.11, down from 2.83 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for MGNX reached as high as 2201.54 in Q4 2024 and fell as low as 9696.83 in Q2 2024.
- Historically, Interest Coverage Ratio has averaged 737.65 across 5 years, with a median of 6.11 in 2026.
- Across the five-year window, Interest Coverage Ratio plunged 45039.17% in 2024 and surged 99.53% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 73.71 in 2022, then surged by 70.86% to 21.48 in 2023, then surged by 10348.27% to 2201.54 in 2024, then tumbled by 100.13% to 2.83 in 2025, then slumped by 115.92% to 6.11 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 6.11 in Q1 2026, 2.83 in Q4 2025, and 5.58 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - | -6.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.11 |
| Dec 31, 2025 | -2.83 |
| Sep 30, 2025 | 5.58 |
| Jun 30, 2025 | -45.83 |
| Mar 31, 2025 | -468.40 |
| Dec 31, 2024 | 2,201.54 |
| Jun 30, 2024 | -9,696.83 |
| Mar 31, 2024 | -1.16 |
| Jun 30, 2023 | -21.48 |
| Mar 31, 2023 | -4.91 |
| Mar 31, 2022 | -73.71 |
| Dec 31, 2021 | -0.18 |
| Sep 30, 2021 | -2.66 |
| Jun 30, 2021 | -0.75 |
| Mar 31, 2021 | -0.56 |
| Dec 31, 2020 | -0.01 |
| Sep 30, 2020 | -0.93 |
| Jun 30, 2020 | -0.87 |
| Mar 31, 2020 | -38.35 |
| Dec 31, 2019 | -24.16 |